Send a message to the show! While structured data elements such as patient identifier, medicine name and reaction, are fundamental for adverse event reporting, they may not capture all relevant details. This is where the narrative fields come in, allowing reporters to disclose important contextual information, such as the patient’s full clinical course. But ... Show More
Feb 2026
#44 Rethinking medical device safety, part 2 – Omar Aimer
Send a message to the show!Medical device pharmacovigilance is complicated. Alongside clinical safety, there are technology risks, from cybersecurity threats to outdated software, that can put patients at risk. In this two-part episode, Omar Aimer, President of ISoP and former co ... Show More
21m 22s
May 2022
Patient-Reported Outcomes in Clinical Trials
<p>JAMA Associate Editor Ethan Basch, MD, and Melanie Calvert, PhD, from the University of Birmingham, UK, discuss barriers to and strategies for including rigorous patient-reported outcomes in clinical trials, and reflect on Dr Calvert's recent JAMA paper on related ethical impl ... Show More
14m 26s
Jul 2022
Talk Evidence - shoulders, knees, and woes
In this episode, Juan Franco, editor in chief of BMJ EBM, and Helen Macdonald, The BMJ's research integrity editor, sit down to discuss what's new in the world of evidence.
Firstly, last week they went to the first EBM Live conference for two years - and report back on what happ ... Show More
37m 45s
May 2025
Rare Insights: Navigating Medical Affairs in Rare Disease Launches with Eva Gallagher, PhD, CNMAP
In the latest episode of Medical Affairs unscripted, Peg Crowley-Nowick, PhD and Senior Advisor, Medical Affairs Consulting at Lumanity, engages in a compelling conversation with Eva Gallagher, PhD, CNMAP, VP, Head of Medical Affairs at Agios Pharmaceuticals. They explore the str ... Show More
44m 43s
Jan 2023
Cultivating Curiosity: Mysteries, Stories, and Critical Reflection
Exploring mysteries, being inquisitive, and approaching the world with a sense of wonder are at the very heart of the academy. In this epidose, Jeff leads a discussion about curiosity. Dr. Daniel Malcom shares with us the connection between aviation "incidents" and drug safety .. ... Show More
31m 48s
Mar 2023
Using Real-World Studies to Compare DMTs in MS
Tomas Kalincik, Head of the Clinical Outcomes Research Unit at the University of Melbourne, and Maria Pia Sormani, Professor of Biostatistics at the University of Genoa, discuss the use of real-world data to compare disease-modifying treatments (DMTs) in multiple sclerosis, inclu ... Show More
24m 43s
Apr 2021
Clinical Implications & Application of Pharmacogenomics | PGX for Pharmacists
Behnaz Sarrami, MS, PharmD, a PGx for pharmacists podcast, joins Cari Lalande, PharmD where we discuss the clinical value and utility of PGx and how it can be implemented in a clinical setting.
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. ... Show More
24m 6s